2Sciarretta S, Paneni F, Palano F, et al. Role of the rennin - angiotensin - aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction [ J ]. Clin Sci ( Lond ), 2009, 116(6) :467.
3Dickstein K, Cohen - Solal A, Filippatos G, eta. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in col- laboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine (ESICM) [ J ]. Eur Heart J,2008,29 ( 19 ) :2388.
4Alehagen U, Dahlstrom U, Lindahl TL. Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortal- ity in elderly patients with heart failure:results from a 10 -year study in primary care[ J ]. Eur J Heart Fail. 2009,11 (4) :354.
5Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incor- porated into the ACC/AHA 2005 Guidelines for the Diagnosis and Man- agement of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Prac- tice Guidelines Developed in Collaboration With the International Socie- ty for Heart and Lung Transplantation[J]. J Am Coil Cardiol. 2009,53 (15) :el.
6Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure : an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchroniza- tion therapy. Developed with the special contribution of the Heart Fail- ure Association and the European Heart Rhythm Association [ J ]. Eur Heart J,2010,31 (21) :2677.
